SAB Biotherapeutics (SABS) Treasury Shares (2022 - 2026)
SAB Biotherapeutics (SABS) posted Treasury Shares of $5.5 million for Q1 2026, little changed on a QoQ basis from $5.5 million in Q4 2025, and little changed year-over-year from $5.5 million in Q1 2025.
SAB Biotherapeutics (SABS) Treasury Shares (2022 - 2026) Analysis & Trends
SAB Biotherapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $5.5 million for Q1 2026.
- Quarterly Treasury Shares changed 0.0% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $5.5 million, changed 0.0% from the prior year.
- Treasury Shares was $5.5 million for Q1 2026 at SAB Biotherapeutics, roughly flat from $5.5 million in the prior quarter.
- Across five years, Treasury Shares topped out at $668875.0 in Q1 2023 and bottomed at -$54665.0 in Q4 2023.
- A 5-year average of $194197.3 and a median of $54665.0 in 2022 frame the typical range for Treasury Shares.
- Peak annual rise in Treasury Shares reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
- SAB Biotherapeutics' Treasury Shares stood at $5.5 million in 2022, then changed by 0.0% to $5.5 million in 2023, then changed by 0.0% to $5.5 million in 2024, then changed by 0.0% to $5.5 million in 2025, then changed by 0.0% to $5.5 million in 2026.
- Business Quant data shows SABS's Treasury Shares at $5.5 million in Q1 2026, $5.5 million in Q4 2025, and $5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | 54,665.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.52 Mn |
| Mar 31, 2026 | 54,665.00 |
| Mar 31, 2026 | 5.52 Mn |
| Mar 31, 2026 | 54,665.00 |
| Dec 31, 2025 | 54,665.00 |
| Dec 31, 2025 | 5.52 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Dec 31, 2025 | 54,665.00 |
| Sep 30, 2025 | 5.52 Mn |
| Sep 30, 2025 | 54,665.00 |
| Sep 30, 2025 | 54,665.00 |
| Sep 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | -54,665.00 |
| Jun 30, 2025 | -54,665.00 |
| Mar 31, 2025 | 5.52 Mn |
| Mar 31, 2025 | -54,665.00 |
| Mar 31, 2025 | -54,665.00 |
| Mar 31, 2025 | 5.52 Mn |